BIG
PFE icon

Boothe Investment Group’s Pfizer PFE Stock Holding History

Boothe Investment Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.52M Buy
353,811
+2,726
+0.8% +$71.3K 2.68% 13
2026
Q1 		$9.86M Buy
351,085
+7,175
+2% +$191K 3.17% 10
2025
Q4 		$8.56M Buy
343,910
+13,960
+4% +$352K 3.06% 12
2025
Q3 		$8.41M Buy
329,950
+5,393
+2% +$133K 3.08% 11
2025
Q2 		$7.87M Buy
324,557
+47,261
+17% +$1.1M 3% 13
2025
Q1 		$7.03M Buy
277,296
+7,804
+3% +$204K 3.2% 12
2024
Q4 		$7.15M Buy
269,492
+42,773
+19% +$1.16M 3.1% 12
2024
Q3 		$6.56M Buy
226,719
+178,808
+373% +$5.22M 3% 13
2024
Q2 		$1.35M Buy
+47,911
New +$1.32M 0.63% 32

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boothe Investment Group's PFE Position: Q2 2026 in Review

Boothe Investment Group increased its Pfizer (PFE) stake by 0.78% in Q2 2026, buying an estimated $71.3K and bringing the position to 353,811 shares worth $8.52M. The position accounts for 2.68% of the portfolio, ranked #13.

Boothe Investment Group first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.86M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Boothe Investment Group held 353,811 shares of Pfizer worth $8.52M as of Q2 2026.
  • Boothe Investment Group bought 2,726 Pfizer shares in Q2 2026, an estimated $71.3K.
  • Pfizer made up 2.68% of Boothe Investment Group's portfolio in Q2 2026, its #13 holding.
  • Boothe Investment Group first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Boothe Investment Group's Pfizer position peaked at $9.86M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boothe Investment Group's 13F filing for Q2 2026, filed 14 Jul 2026.